| Record Information |
| Version |
3.5 |
| Creation Date |
2006-03-08 05:54:47 -0700 |
| Update Date |
2013-02-08 17:10:57 -0700 |
| HMDB ID |
HMDB01892 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Menadione |
| Description |
Menadione is a synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo. -- Pubchem; Despite the fact that it can serve as a precursor to various types of vitamin K, menadione is generally not used as a nutritional supplement. Large doses of menadione have been reported to cause adverse outcomes including hemolytic anemia due to G6PD deficiency, neonatal brain or liver damage, or neonatal death in some cases. Moreover, menadione supplements have been banned by the FDA because of their high toxicity. It is sometimes called vitamin K3, although derivatives of naphthoquinone without the sidechain in the 3-position cannot exert all the functions of the K vitamins. Menadione is a vitamin precursor of K2 which utilizes alkylation in the liver to yield menaquinones (MK-n, n=1-13; K2 vitamers), and hence, is better classified as a provitamin. -- Wikipedia. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 2-Methyl-1,4-naftochinon
- 2-Methyl-1,4-naphthalendione
- 2-Methyl-1,4-naphthalenedione
- 2-Methyl-1,4-naphthochinon
- 2-Methyl-1,4-naphthodione
- 2-Methyl-1,4-naphthoquinone
- 2-Methylnaphthoquinone
- 3-Methyl-1,4-naphthoquinone
- Aquakay
- Aquinone
- Hemodal
- Juva-K
- K-Thrombyl
- K-Vitan
- Kaergona
- Kanone
- Kappaxan
- Kappaxin
- Karcon
- Kareon
- Kativ-G
- Kayklot
- Kaykot
- Kaynone
- Kayquinone
- Kipca
- Kipca-Oil Soluble
- Klottone
- Koaxin
- Kolklot
- Menadion
- Menadione
- Menaphthene
- Menaphthon
- Menaphthone
- Menaphtone
- Menaquinone
- Menaquinone O
- Mitenon
- Mitenone
- MNQ
- Panosine
- Prokayvit
- Synkay
- Thyloquinone
- Vitamin K0
- Vitamin K2
- Vitamin K3
- Vitamin K3: 1,4-Dihydro-1,4-dioxo-2-methylnaphthalene
|
| Chemical Formula |
C11H8O2 |
| Average Molecular Weight |
172.18 |
| Monoisotopic Molecular Weight |
172.0524295 |
| IUPAC Name |
2-methyl-1,4-dihydronaphthalene-1,4-dione |
| Traditional IUPAC Name |
menadione |
| CAS Registry Number |
58-27-5 |
| SMILES |
CC1=CC(=O)C2=CC=CC=C2C1=O |
| InChI Identifier |
InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3 |
| InChI Key |
MJVAVZPDRWSRRC-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aromatic Homomonocyclic Compounds |
| Class |
Acenes |
| Sub Class |
Naphthalenes |
| Other Descriptors |
- Aromatic Homomonocyclic Compounds
- Aromatic Homopolycyclic Compounds
- Fat-soluble vitamins(KEGG)
- Vitamin K(KEGG)
- a vitamin K(Cyc)
- naphthoquinone(ChEBI)
|
| Substituents |
|
| Direct Parent |
Naphthoquinones |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
|
| Application |
Not Available |
| Cellular locations |
Not Available |
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
107 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
0.160 mg/mL at 30 °C |
YALKOWSKY,SH & DANNENFELSER,RM (1992) |
| LogP |
2.20 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
Not Available
|
| Biofluid Locations |
|
| Tissue Location |
- Fibroblasts
- Neuron
- Pancreas
- Placenta
- Kidney
- Liver
- Prostate
- Platelet
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Normal |
Inferred from detection in urine
|
| Urine |
Detected and Quantified |
|
0.00108 (0.0003-0.025) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.000411(0.0001-0.0011) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
DB00170  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB000953 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
3915  |
| KEGG Compound ID |
C05377  |
| BioCyc ID |
CPD-3766  |
| BiGG ID |
Not Available |
| Wikipedia Link |
Menadione  |
| NuGOwiki Link |
HMDB01892  |
| Metagene Link |
HMDB01892  |
| METLIN ID |
3910  |
| PubChem Compound |
4055  |
| PDB ID |
VK3  |
| ChEBI ID |
28869  |
| References |
| Synthesis Reference |
Minami, Ryohei; Nishizaki, Tadao; Kumagai, Yoshitoshi. Menadione. Jpn. Kokai Tokkyo Koho (1986), 4 pp. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Robertson DG, Bailey DL, Martin RA: Species differences in response to photohemolytic agents. Photochem Photobiol. 1991 Apr;53(4):455-61.
Pubmed: 1857739
- Chladek J, Martinkova J, Sispera L: An in vitro study on methotrexate hydroxylation in rat and human liver. Physiol Res. 1997;46(5):371-9.
Pubmed: 9728483
- Habu D, Shiomi S, Tamori A, Takeda T, Tanaka T, Kubo S, Nishiguchi S: Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA. 2004 Jul 21;292(3):358-61.
Pubmed: 15265851
- Lasalvia-Prisco E, Cucchi S, Vazquez J, Lasalvia-Galante E, Golomar W, Gordon W: Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer. Med Oncol. 2003;20(1):45-52.
Pubmed: 12665684
- Harrington DJ, Soper R, Edwards C, Savidge GF, Hodges SJ, Shearer MJ: Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res. 2005 May;46(5):1053-60. Epub 2005 Feb 1.
Pubmed: 15722567
- Kwasnicka-Crawford DA, Vincent SR: Role of a novel dual flavin reductase (NR1) and an associated histidine triad protein (DCS-1) in menadione-induced cytotoxicity. Biochem Biophys Res Commun. 2005 Oct 21;336(2):565-71.
Pubmed: 16140270
- Snider BJ, Moss JL, Revilla FJ, Lee CS, Wheeler VC, Macdonald ME, Choi DW: Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults. Neuroscience. 2003;120(3):617-25.
Pubmed: 12895502
- Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K: Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr. 1990 May;51(5):846-52.
Pubmed: 2333843
- Ono M, Ohta H, Ohhira M, Sekiya C, Namiki M: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma. Am J Gastroenterol. 1990 Sep;85(9):1149-54.
Pubmed: 1697141
- Suzuki S, Iwata G, Sutor AH: Vitamin K deficiency during the perinatal and infantile period. Semin Thromb Hemost. 2001;27(2):93-8.
Pubmed: 11372776
- Wermuth B, Platts KL, Seidel A, Oesch F: Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Biochem Pharmacol. 1986 Apr 15;35(8):1277-82.
Pubmed: 3083821
- Price RJ, Mistry H, Wield PT, Renwick AB, Beamand JA, Lake BG: Comparison of the toxicity of allyl alcohol, coumarin and menadione in precision-cut rat, guinea-pig, cynomolgus monkey and human liver slices. Arch Toxicol. 1996;71(1-2):107-11.
Pubmed: 9010592
- Thijssen HH, Drittij-Reijnders MJ: Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br J Nutr. 1996 Jan;75(1):121-7.
Pubmed: 8785182
- Iioka H, Moriyama IS, Morimoto K, Akada S, Hisanaga H, Ishihara Y, Ichijo M: Pharmacokinetics of vitamin K in mothers and children in the perinatal period: transplacental transport of vitamin K2 (MK-4). Asia Oceania J Obstet Gynaecol. 1991 Mar;17(1):97-100.
Pubmed: 2064595
- Strunnikova N, Hilmer S, Flippin J, Robinson M, Hoffman E, Csaky KG: Differences in gene expression profiles in dermal fibroblasts from control and patients with age-related macular degeneration elicited by oxidative injury. Free Radic Biol Med. 2005 Sep 15;39(6):781-96.
Pubmed: 16109308
|
| Enzymes |
|
|
| Name: |
Aldehyde oxidase
|
| Reactions: |
- an aldehyde + H2O + O2 = a carboxylic acid + H2O2 [RN:R00635]
|
| Gene Name: |
AOX1 |
| Uniprot ID: |
Q06278  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Cytochrome P450 1A1
|
| Reactions: |
- RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O [RN:R04122]
|
| Gene Name: |
CYP1A1 |
| Uniprot ID: |
P04798  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Cytochrome P450 1A2
|
| Reactions: |
- RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O [RN:R04122]
|
| Gene Name: |
CYP1A2 |
| Uniprot ID: |
P05177  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Cytochrome P450 2A6
|
| Reactions: |
- RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O [RN:R04122]
|
| Gene Name: |
CYP2A6 |
| Uniprot ID: |
P11509  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Coagulation factor X
|
| Reactions: |
- Selective cleavage of Arg!Thr and then Arg!Ile bonds in prothrombin to form thrombin
|
| Gene Name: |
F10 |
| Uniprot ID: |
P00742  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Coagulation factor VII
|
| Reactions: |
- Selective cleavage of Arg!Ile bond in factor X to form factor Xa INHIBITOR Isoflurophate [CPD:C00202]
|
| Gene Name: |
F7 |
| Uniprot ID: |
P08709  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|